908 Devices Inc. a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, announces that it has entered the initial production phase of the Aerosol and Vapor Chemical Agent Detector (AVCAD) program. The company and its partner on the project, Smiths Detection, will initially produce 122 systems in this next phase.
The systems, which have been in development and testing since 2019, are a next generation chemical detector, designed to detect, identify, alarm and report the presence of traditional and advanced threat vapors and aerosols. Using a wireless remote alarm capability, the AVCAD, which can be mounted or portable, will support missions for the U.S. Army, Navy, Coast Guard, and Marine Corps.
To ensure the highest level of detection and to meet the key deployment needs of the U.S. Department of Defense, the AVCAD features the company’s High Pressure Mass Spectrometry (HPMS) technology. Mass spectrometry is considered to be the gold standard of analytical lab techniques. 908 Devices’ proprietary HPMS technology leverages micro scale geometries and high frequency electronics to enable an efficient regime of vacuum operation for a significant reduction in device size and power consumption compared to conventional lab instruments.
“908 Devices is pleased to continue working with the U.S. Department of Defense and our partner, Smiths Detection, on this enterprise, multi-year program,” said Kevin J. Knopp, CEO and Co-founder of 908 Devices. “Being selected for this limited production phase validates our technology as a new standard for chemical detection and we are truly honored to have a role in protecting our U.S. military.”
About 908 Devices
908 Devices is revolutionizing chemical and biochemical analysis with its simple handheld and desktop devices, addressing critical-to-life applications. The Company’s devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the most critical problems in life sciences research, bioprocessing, pharma/biopharma, forensics and adjacent markets. The Company is headquartered in the heart of Boston, where it designs and manufactures innovative products that bring together the power of mass spectrometry, microfluidic sampling and separations, software automation, and machine learning.